Literature DB >> 24638238

Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.

N Tselis1, U Maurer, W Popp, H Sack, N Zamboglou.   

Abstract

INTRODUCTION: The German Society of Radiation Oncology initiated a multicenter trial to evaluate core processes and subprocesses of radiotherapy by prospective evaluation of all important procedures in the most frequent malignancies treated by radiation therapy. The aim of this analysis was to assess the required resources for interstitial high-dose-rate (HDR) and low-dose-rate (LDR) prostate brachytherapy (BRT) based on actual time measurements regarding allocation of personnel and room occupation needed for specific procedures. PATIENTS AND METHODS: Two radiotherapy centers (community hospital of Offenbach am Main and community hospital of Eschweiler) participated in this prospective study. Working time of the different occupational groups and room occupancies for the workflow of prostate BRT were recorded and methodically assessed during a 3-month period.
RESULTS: For HDR and LDR BRT, a total of 560 and 92 measurements, respectively, were documented. The time needed for treatment preplanning was median 24 min for HDR (n = 112 measurements) and 6 min for LDR BRT (n = 21). Catheter implantation with intraoperative HDR real-time planning (n = 112), postimplantation HDR treatment planning (n = 112), and remotely controlled HDR afterloading irradiation (n = 112) required median 25, 39, and 50 min, respectively. For LDR real-time planning (n = 39) and LDR treatment postplanning (n = 32), the assessed median duration was 91 and 11 min, respectively. Room occupancy and overall mean medical staff times were 194 and 910 min respectively, for HDR, and 113 and 371 min, respectively, for LDR BRT.
CONCLUSION: In this prospective analysis, the resource requirements for the application of HDR and LDR BRT of prostate cancer were assessed methodically and are presented for first time.

Entities:  

Mesh:

Year:  2014        PMID: 24638238     DOI: 10.1007/s00066-013-0515-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

1.  Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources.

Authors:  R Esco; A Palacios; J Pardo; A Biete; J A Carceller; C Veiras; G Vazquez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

2.  Preliminary analysis of the resources in brachytherapy in Europe and its variability of use.

Authors:  F Guedea; T Ellison; G Heeren; M Ventura; G François; J J Mazeron; B Cottier; J López Torrecilla; P Bilbao; M Taillet; J M Borras
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

3.  [Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].

Authors:  A Zabel-du Bois; S Milker-Zabel; M Henzel; W Popp; J Debus; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

4.  American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.

Authors:  Brian J Davis; Eric M Horwitz; W Robert Lee; Juanita M Crook; Richard G Stock; Gregory S Merrick; Wayne M Butler; Peter D Grimm; Nelson N Stone; Louis Potters; Anthony L Zietman; Michael J Zelefsky
Journal:  Brachytherapy       Date:  2012 Jan-Feb       Impact factor: 2.362

5.  Brachytherapy practice across Canada: A survey of workforce and barriers.

Authors:  Jim Rose; Pierre-Yves McLaughlin; Conrad B Falkson
Journal:  Brachytherapy       Date:  2013-09-17       Impact factor: 2.362

6.  Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial.

Authors:  R Fietkau; W Budach; N Zamboglou; H-J Thiel; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

7.  Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat, and treatment techniques based on data from 2007.

Authors:  Gregor Goldner; Samir Sljivic; Renee Oismueller; Johanna Salinger; Michael Mittermüller; Tanja Langsenlehner; Walter Harder; Gerhard Kametriser; Helmut Eiter; Elisabeth Nechvile
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

8.  Overview of brachytherapy resources in Latin America: a patterns-of-care survey.

Authors:  Ferran Guedea; Montse Ventura; Bradley Londres; Luis Pinillos; Adela Poitevin; Rosalba Ospino; Andres Cordova; Rolando Camacho; Ricardo Britton; Gustavo Sarria; Pilar Sempere; Rene Luis Delgado; Ricardo Bulnes; Nalya Cruz Ventura; Erik Van Limbergen; Christine Haie-Meder; Gyorgy Kovacs
Journal:  Brachytherapy       Date:  2011-02-04       Impact factor: 2.362

9.  Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.

Authors:  Anthony V D'Amico; Richard Whittington; S Bruce Malkowicz; Kerri Cote; Marian Loffredo; Delray Schultz; Ming-Hui Chen; John E Tomaszewski; Andrew A Renshaw; Alan Wein; Jerome P Richie
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

10.  Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.

Authors:  Razvan M Galalae; Alvaro Martinez; Tim Mate; Christina Mitchell; Gregory Edmundson; Nils Nuernberg; Stephen Eulau; Gary Gustafson; Michael Gribble; Gyoergy Kovács
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-15       Impact factor: 7.038

View more
  2 in total

1.  Application of a hydrogel spacer for postoperative salvage radiotherapy of prostate cancer.

Authors:  Michael Pinkawa; Carolin Schubert; Nuria Escobar-Corral; Richard Holy; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2014-10-23       Impact factor: 3.621

2.  Accurate method for evaluating the duration of the entire radiotherapy process.

Authors:  Chenlei Guo; Peng Huang; Yexiong Li; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2020-07-25       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.